AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 270 filers reported holding AVANOS MED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $569,251 | -11.9% | 25,379 | -20.6% | 0.02% | -16.7% |
| Q3 2023 | $646,494 | -22.0% | 31,973 | -1.4% | 0.02% | -10.0% |
| Q2 2023 | $828,860 | -1.4% | 32,428 | +14.7% | 0.02% | -13.0% |
| Q1 2023 | $841,017 | -19.3% | 28,279 | -26.6% | 0.02% | -23.3% |
| Q4 2022 | $1,042,541 | +13.6% | 38,527 | -8.6% | 0.03% | 0.0% |
| Q3 2022 | $918,000 | -10.6% | 42,139 | +12.2% | 0.03% | 0.0% |
| Q2 2022 | $1,027,000 | -20.9% | 37,553 | -3.1% | 0.03% | +15.4% |
| Q1 2022 | $1,298,000 | -35.7% | 38,740 | -33.5% | 0.03% | -33.3% |
| Q4 2021 | $2,019,000 | -2.0% | 58,234 | -11.8% | 0.04% | -26.4% |
| Q3 2021 | $2,061,000 | +13.6% | 66,042 | +32.3% | 0.05% | -7.0% |
| Q2 2021 | $1,815,000 | +8.1% | 49,912 | +30.0% | 0.06% | -9.5% |
| Q1 2021 | $1,679,000 | – | 38,380 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |